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Abstract
Limited data are available on the use of coronary computed tomography angiography (CCTA) in
patients who have received percutaneous coronary intervention (PCI). To evaluate patterns of
cardiac testing including CCTA after PCI, we created a retrospective observational data set linking
the National Cardiovascular Data Registry® CathPCI Registry® baseline data with longitudinal
inpatient and outpatient Medicare claims data for patients who received coronary stenting between
November 1, 2005 and December 31, 2007. Among 192,009 PCI patients (median age 74 years),
the first test after coronary stenting was CCTA for 553 (0.3%), stress testing for 89,900 (46.8%),
and coronary angiography for 22,308 (11.6%); 79,248 (41.3%) had no further testing. Patients
referred to CCTA first had generally similar or lower baseline risk than those referred for stress
testing or catheterization first. Compared to patients with stress testing first after PCI, patients who
underwent CCTA first had higher unadjusted rates of subsequent noninvasive testing (10% vs.
3%), catheterization (26% vs. 15%), and revascularization (13% vs. 8%) within 90 days of initial
post-PCI testing (p<0.0001 for all). In conclusion, despite similar or lesser risk profiles, patients
initially evaluated with CCTA after PCI had more downstream testing and revascularization than
patients initially evaluated with stress testing. It is unclear whether these differences derive from
patient selection, the performance of CCTA relative to other testing strategies, or the association
of early CCTA adoption with distinct patterns of care.
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We analyzed the use of diagnostic modalities for CAD after coronary stent implantation
among Medicare fee-for-service beneficiaries, utilizing a combined data set comprised of
inpatient and outpatient claims from the Centers for Medicare & Medicaid Services (CMS)
and data from the National Cardiovascular Data Registry® CathPCI Registry®. Our aim was
to provide insight into emerging patterns of testing with computed coronary tomography
angiography (CCTA) relative to alternative testing options in patients after percutaneous
coronary intervention (PCI) procedures between 2005 and 2007, as well as the association of
initial test choice with downstream testing and procedures, including subsequent
catheterization and revascularization.
Methods
The Duke University Medical Center Institutional Review Board granted a waiver of
informed consent and authorization for this study, and all analyses were conducted by the
Duke Clinical Research Institute.
Percutaneous coronary intervention cases were drawn from the CathPCI Registry—a large,
national registry of patients who have received diagnostic cardiac catheterization or PCI.1,2
Initially, we identified patients at least 65 years of age who received PCI with stenting and
who were admitted and discharged between January 2004 and December 2008. The first PCI
procedure with stent for each admission was considered the index event and was the initial
unit of analysis. Initially, there were 672,617 eligible index events from the CathPCI
Registry. Index PCI events were linked to Medicare inpatient claims data from 2004 to 2008
using an established methodology.3 We successfully linked 67% of all eligible index events
to an admission in the CMS data. The resulting match allowed identification of subsequent
resource use in the CMS inpatient, outpatient, and physician claims files.
A number of exclusion criteria were applied to define the final study population, including
limiting the cohort for the current study to those with PCI between November 1, 2005 and
December 31, 2007 to account for changes in coding for CCTA and to allow for at least one
year of potential follow up, as detailed in Figure 1. We defined a 60-day blackout period
after PCI for each patient during which tests or procedures were not considered in the final
study analysis, because these tests and procedures may have been performed for purposes of
cardiac rehabilitation, staging of procedures, or functional capacity assessments. Patients
were excluded if they died or did not retain both Part A and Part B Medicare coverage
during this blackout period.
The number and dates of noninvasive cardiac stress tests and procedures after index PCI
were identified by Current Procedural Technology (CPT) and Healthcare Common
Procedure Coding System (HCPCS) codes (electrocardiogram [ECG] stress, 93015–93018;
nuclear, 78460, 78461, 78464, 78465, 78472, 78473, 78481, 78483; positron emission
tomography [PET], 78491, 78492; stress echocardiography, 93350; CCTA, 0146T–0149T).
We stratified patients based on the type of the first diagnostic test they received after their
coronary stenting (after a 60-day blackout period). The number and dates of repeat
catheterizations and coronary revascularization (PCI or coronary artery bypass grafting
[CABG] surgery) after PCI were identified using CPT and International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and HCPCS codes
(catheterization, 93508, 93539, 93540, 93545; PCI, 92980-92982, 92984, 92995, 92996,
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G0290, G0291, 36.01, 36.02, 36.05, 36.06, 36.07, 00.66; CABG, 33510-33514,
33516-33519, 33521-33523, 33533-33536, 36.1x, 36.2, S2205-S2209).
Demographic, clinical, and hospital baseline characteristics for patients at the time of index
PCI were analyzed overall and by type of initial test (if any) performed after coronary
stenting at any time during the study period using descriptive statistics (number of
observations, mean, standard deviation, median, 25th and 75th percentiles, minimum, and
maximum) for numerical (or continuous) variables and with frequency and percentage for
categorical variables. All statistical tests were two-sided with a significance level of 0.05. P-
values were based on Pearson chi-square tests for categorical variables or Kruskal-Wallis
tests for continuous or ordinal variables.
Using cumulative incidence functions that accounted for administrative censoring and
included death as a competing risk, we computed and plotted time to the first test (e.g.,
CCTA, stress test, or catheterization) occurring at least 60 days and up to 1 year after the
index revascularization episode. Cumulative incidence across groups was compared using
Gray's method.4
One-year cumulative incidence rates were used to evaluate quarterly time trends for first
noninvasive cardiac test or invasive coronary angiography after coronary stenting. We used
an unadjusted Poisson regression model to determine the significance of the quarterly trends.
To evaluate patterns of “layered” testing after PCI, we calculated rates of invasive and
noninvasive testing and procedures conditional upon the initial test following PCI (e.g.,
CCTA first, stress first, catheterization first, or no subsequent test). We identified
subsequent procedures (e.g., CCTA next, stress next, any catheterization, any
revascularization, or no subsequent procedure) occurring within a 90-day “episode of care”
window after the initial post-PCI cardiac test and calculated the rates of additional
noninvasive testing, diagnostic catheterization, and coronary revascularization following
initial post-PCI testing. “Catheterization yield” rates were defined as the number of patients
undergoing coronary revascularization within 90 days of the initial post-PCI test divided by
the number of patients undergoing catheterization procedures within the same period.
Time trends of invasive and noninvasive testing and procedures within 90 days after CCTA
as first test following PCI were evaluated by the date of CCTA in half-year increments to
assess whether downstream care patterns after CCTA varied with time. Analysis was limited
to patients with 90 days of follow-up after CCTA. Patients with CCTA from January 1,
2006, through June 30, 2006, were excluded, due to very small numbers. An unadjusted
negative binomial regression model was used to determine the significance of the time
trends.
All statistical analyses were conducted using SAS version 9.2 or higher (SAS Institute Inc.,
Cary, North Carolina) and Stata Statistical Software release 11 (StataCorp, College Station,
Texas).
Results
The study population consisted of 192,009 fee-for-service Medicare beneficiaries
undergoing stent implantation from November 1, 2005 to December 31, 2007, with follow-
up from January 1, 2006, to December 31, 2008 (Figure 1). The median duration of follow-
up was 705 days (interquartile range [IQR] 516 to 917 days). Overall, during the entire study
period, 553 (0.3%) patients had CCTA as their first test at least 60 days after coronary
stenting. In contrast, 89,900 (46.8%) patients had a stress test (stress nuclear, stress
echocardiography, or exercise treadmill test) as their first test, 22,308 (11.6%) patients
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underwent coronary angiography as their first test, and 79,248 (41.3%) patients had no
cardiac testing after index PCI (Table 1).
The 553 CCTAs completed as first tests after PCI were performed at 199 sites, with tests per
site ranging from 1 to 33 (median 1, IQR 1 to 3); 106 sites performed only 1 study (106 total
studies; 19%), 85 sites performed between 2 and 9 studies (292 total studies; 53%), and 8
sites performed 10 or more studies (155 total studies; 28%).
Patients with CCTA as their first test after coronary stenting differed at baseline from the
overall study population (Table 1, p<0.0001 for all comparisons). In general, patients
referred for CCTA first after coronary stenting had lower rates of most risk factors and
comorbidities compared to patients referred to cardiac catheterization first and compared to
patients who did not receive further cardiovascular testing during the study period.
Compared to only those patients referred for stress testing first, CCTA patients had
clinically similar rates (within 2%) of most baseline characteristics, cardiac risk factors, and
comorbidities evaluated. Coronary computed tomography angiography patients had
modestly lower rates of hypertension and diabetes, but higher rates of chronic lung disease.
At the time of index PCI, CCTA patients had higher rates of previous revascularization, but
were less likely to have presented with either a myocardial infarction (or no angina). Patients
who received CCTA first had received, on average, slightly larger stents (mean diameter
3.04 mm vs. 2.97 mm; IQR 2.75 to 3.5 mm vs. 2.5 to 3.5 mm) during index PCI, and were
less likely to have received stents less than 3.0 mm in diameter.
Over the study interval, the rate of CCTA use as the first test within 1 year after coronary
stenting was 0.19% (Figure 2; the proportion of patients with CCTA first at any time during
follow-up, median 734 days, was 0.3%). This rate increased over time, rising from 0.13%
for patients with PCI in the fourth quarter (Q4) of 2005 to 0.23% for Q4 2007. Over the
same period, stress testing first declined from 34.7% to 30.7%, coronary angiography first
increased from 8.6% to 9.0%, and the rate of no subsequent cardiac testing increased from
56.6% to 60.0% (Table 2).
The unadjusted 90-day rates of downstream testing and procedures differed between patients
undergoing CCTA, stress testing, and catheterization first after coronary stenting. Rates
were not adjusted because of the small number of CCTA patients (Table 3, Figure 3). A
higher proportion of CCTA patients compared to stress test patients received additional
noninvasive testing as the next test or received invasive coronary angiography within 90
days. The overall revascularization rate (portion receiving revascularization within 90 days)
was higher among patients referred for CCTA rather than stress testing as the initial
evaluation, but the “catheterization yield” (percentage receiving revascularization among
those referred for catheterization) was similar among groups. For CCTA patients, the rates
of subsequent testing did not vary significantly over time (Table 4).
Among patients undergoing CCTA first after PCI, those who received stents less than 3 mm
in diameter (n=184), compared to those who did not (n=363), were significantly more likely
to undergo CCTA, stress testing, or catheterization within 90 days (40% vs. 31%; p=0.03),
with statistically insignificant (but numerically higher) rates of subsequent noninvasive
testing next (13% vs. 9%), catheterization (30% vs. 23%) within 90 days, and
revascularization (14% vs. 12%). “Catheterization yield” was lower but not statistically
different for those with stents less than 3 mm in diameter (45% vs. 53%; p=0.34).
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With the development of a unique data set linking detailed clinical patient information from
the CathPCI Registry data with Medicare fee-for-service longitudinal administrative data,
we were able to evaluate inpatient and outpatient care patterns after PCI among 192,009
Medicare beneficiaries during an early adoption period for CCTA. A small but growing
number of patients received CCTA first during the study period; when compared with
patients referred to stress testing first, these CCTA patients had substantially higher
downstream rates of additional noninvasive testing, cardiac catheterization, and
revascularization.
In patients without prior revascularization or CAD diagnosis, retrospective studies and
decision analysis models have suggested that evaluation with CCTA compared to nuclear
stress testing may lead to lower rates of downstream diagnostic coronary angiography and
coronary revascularization, with resulting lower health care costs but with similar short to
intermediate rates of cardiac clinical events.5-7 In contrast, we found in the current study that
elderly patients referred to CCTA after PCI had higher rates of subsequent noninvasive
testing, diagnostic catheterization, and revascularization than stress test patients (Table 3).
Higher downstream procedure rates for CCTA patients compared to stress test patients may
reflect differences in the 2 populations in this nonrandomized observational study. For
example, higher rates of previous revascularization prior to index PCI among CCTA-first
patients compared to stress test patients (59% vs. 47%) may indicate more aggressive
coronary disease in this subgroup. However, CCTA patients otherwise shared quite similar
rates of risk factors with stress patients, had lower rates of diabetes and hypertension, and
were less likely to have had myocardial infarction as the indication for index PCI.
Alternatively, the choice of initial testing strategy may influence subsequent care due to
characteristics of the test and resulting care patterns. While CCTA is a very sensitive test for
ruling out obstructive coronary artery disease (CAD), a positive finding on CCTA may not
be specific for functionally significant disease and may lead to further evaluation. In patients
without known CAD, the specificity of 64-slice CCTA relative to invasive angiography is
estimated at 85%.8
In patients with coronary stents, particularly stents of a smaller diameter, technical
limitations may lead to a significant number of uninterpretable studies and significantly
decrease the sensitivity for in-stent restenosis.9,10 Current American College of Cardiology
Foundation (ACCF) Appropriate Use Criteria (AUC) guidelines deem the use of CCTA for
patients with stents less than 3 mm in diameter “inappropriate.”11 In this study, although
CCTA patients were less likely than stress test patients to have received stents less than 3
mm in diameter, more than one-third had received stents of that caliber. Following CCTA,
those patients with small-caliber stents were more likely to have subsequent noninvasive
testing, catheterization, and revascularization within 90 days than those with only stents
larger than 3 mm in diameter. Even so, CCTA patients with stents greater than 3 mm in
diameter still had a higher incidence of downstream procedures than stress test patients.
Given these concerns, as well as the likely high prevalence of coronary plaques and
calcification in this elderly CAD population, it is probable that frequent abnormal or
equivocal findings on CCTA contributed to relatively high rates of additional cardiac testing
—particularly cardiac catheterization. This hypothesis is also supported by the fairly similar
“catheterization yields” in patients undergoing each of the 3 testing arms: CCTA, stress
testing, or catheterization. While prior studies have also documented similar rates of
revascularization after catheterization in post-PCI patients being treated with a stress versus
catheterization strategy,12 it is unclear why the “catheterization yield” in CCTA patients was
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not higher than either of these other 2 groups. Regardless of the reason, the higher
catheterization rate may help explain the increased rate of revascularization after CCTA;
Lucas et al. have previously demonstrated a close correlation between cardiac
catheterization rates and subsequent rates of PCI,13 presumably because of the visually
compelling nature of stenotic lesions on angiography.
Higher downstream testing rates after CCTA may also reflect the newness of the application
during the study period, when technology, protocols, and utilization patterns were evolving
rapidly. As new technologies are adopted and refined, high initial rates of confirmatory
testing may decline over time as confidence grows.14 Nevertheless, we were unable to detect
any changes over time in the relatively higher usage of subsequent noninvasive testing,
catheterization, or revascularization after CCTA in the post-PCI population during the study
period (Table 4).
Another possible explanation for our findings is that providers who were early adopters of
CCTA technology during the study period may have had distinct practice patterns compared
to other providers. Without data on clinical outcomes, we are unable to determine whether
one diagnostic strategy after PCI is preferable to another.
This study had several limitations. First, the small number of patients who underwent CCTA
first after receiving PCI may limit the generalizability of these findings. Second, the
population is limited to fee-for-service Medicare patients (age 65 or older) and those
enrolled in the CathPCI Registry. Third, data on symptoms, clinical presentation, and
findings at the time of retesting are unavailable. Fourth, given the increased experience with
CCTA and technological advances over time, findings may not reflect current patterns of
CCTA use. Finally, we did not have access to information on the quality of test
performance, the type of equipment used (such as the number of detectors for CCTA), or the
accuracy of test interpretation.
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Description of: (A) the primary study data set, created using a probabilistic matching
algorithm to link the CMS and NCDR CathPCI Registry data set populations; and (B)
inclusion, exclusion, and cohort derivation for the CCTA study population.
BMS = bare metal stent; CCTA = coronary computed tomography angiography; CMS =
Centers for Medicare & Medicaid Services; DES = drug-eluting stent; MRI = magnetic
resonance imaging; NCDR = National Cardiovascular Data Registry; PCI = percutaneous
coronary intervention; PET = positron emission tomography.
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Cumulative incidence of first noninvasive test, coronary angiography, or death within 1 year
and at least 60 days after index PCI.
Time to the first test (CCTA, stress test, or coronary angiography) or death occurring at least
60 days after index PCI, plotted using cumulative incidence functions accounting for
administrative censoring and competing risk of each end point.
Cath = invasive coronary angiography; CCTA = coronary computed tomography
angiography; PCI = percutaneous coronary intervention; Stress = stress test.
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Patterns of noninvasive testing, coronary angiography, and revascularization after index
PCI.
Testing and procedures after PCI, showing first and second test after PCI and/or any
catheterization or revascularization procedures within 90 days of the first test. “Cath yield”
is the number of revascularization procedures divided by the number of coronary
catheterizations for each testing pattern leading to catheterizations. The diamonds in the top
row of the chart indicate the first test during follow-up. The top row of rectangles shows the
next test within 90 days; the middle and bottom rows of rectangles show all procedures
within 90 days of the first test during follow-up.
*Repeat catheterization but no revascularization within 90 days.
Cath = invasive coronary angiography; CCTA = coronary computed tomography
angiography; Revasc = coronary revascularization (PCI or coronary artery bypass grafting
surgery); Stress = stress test.
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Table 3
Rates of noninvasive testing, coronary angiography, and revascularization within 90 days of first test after
index percutaneous coronary intervention
Variable First Test After Index PCI
CCTA (n = 553) Stress Test (n = 89,900) Catheterization (n = 22,308)





Catheterization within 90 days 26% 15%
Revascularization within 90 days 13% 8% 56%
Catheterization yield
† 50% 49% 56%
All p values < 0.0001 for all comparisons: CCTA versus stress, CCTA versus Catheterization, and Stress versus Catheterization. All abbreviations
can be found in Table 1.
*
Stress test or CCTA.
†
Catheterization yield = revascularizations within 90 days divided by catheterizations within 90 days.
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